BRDG1 Activators
BRDG1 activators encompass a range of compounds that interact with various cellular mechanisms to enhance the functional activity of BRDG1. Phosphatidylinositol 3,4,5-trisphosphate (PIP3), a pivotal second messenger in the PI3K/Akt signaling pathway, directly recruits BRDG1 to the plasma membrane via its pleckstrin homology (PH) domain, leading to BRDG1 activation and subsequent amplification of downstream signaling events. Similarly, lysophosphatidic acid (LPA) activates G protein-coupled receptors (GPCRs), which in turn can initiate the activation of BRDG1 through the RhoA signaling pathway, crucial for actin cytoskeleton reorganization. Prostaglandin E2 (PGE2) engages EP receptors, which are GPCRs that can also elevate BRDG1 activity through receptor-mediated signal transduction, contributing to cytoskeletal reorganization. Moreover, sphingosine-1-phosphate (S1P) activates its receptors, leading to RhoA activation where BRDG1 acts as a mediator, potentially boosting its activity. This direct activation of BRDG1 through ligand-receptor interactions signifies a targeted augmentation of signaling pathways in which BRDG1 is a critical component.
In contrast to these direct activators, there are compounds that indirectly enhance BRDG1 activity by modulating the signaling environment. The Src-family kinase (SFK) inhibitor PP2 leads to compensatory cellular mechanisms that can result in increased BRDG1 activity, maintaining signaling homeostasis. Focal adhesion kinase (FAK) inhibitors, by altering integrin signaling, may also indirectly promote BRDG1 activity, which is vital in integrin-mediated signaling pathways. Calmodulin antagonists such as W-7 can upregulate calcium signaling pathways, indirectly heightening BRDG1 activity due to its calcium-dependent activation mechanisms. Moreover, Phorbol 12-myristate 13-acetate (PMA) is a diacylglycerol (DAG) analog that activates protein kinase C (PKC), which in turn can phosphorylate proteins in BRDG1's signaling pathways, indirectly amplifying BRDG1 signaling. Additionally, inhibition of molecules like Bruton's tyrosine kinase (Btk) with compounds like LFM-A13 may preferentially enhance BRDG1 activity as a compensatory response. These indirect activators demonstrate the complex interplay between different signaling molecules and pathways that converge on the modulation of BRDG1 function.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Src kinase inhibitor I | 179248-59-0 | sc-204303 sc-204303A | 1 mg 10 mg | $53.00 $204.00 | 11 | |
PP2 is an inhibitor of Src-family kinases, which phosphorylate and activate a variety of downstream proteins including BRDG1. By selectively inhibiting SFKs, PP2 can lead to compensatory cellular mechanisms that enhance the activity of BRDG1 as a response to maintain signaling homeostasis. | ||||||
Lysophosphatidic Acid | 325465-93-8 | sc-201053 sc-201053A | 5 mg 25 mg | $98.00 $341.00 | 50 | |
LPA activates G protein-coupled receptors (GPCRs), which can lead to the activation of downstream signaling molecules, including BRDG1. The engagement of GPCRs by LPA triggers RhoA signaling, potentially enhancing the functional activity of BRDG1 in mediating actin cytoskeleton reorganization. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a diacylglycerol (DAG) analog that activates protein kinase C (PKC). PKC can phosphorylate and activate proteins involved in the same signaling pathways as BRDG1, which indirectly enhances BRDG1 activity by increasing the signaling flux through these pathways. | ||||||
FAK Inhibitor 14 | 4506-66-5 | sc-203950 sc-203950A | 10 mg 50 mg | $109.00 $238.00 | 86 | |
The inhibition of FAK can lead to altered integrin signaling, which may indirectly enhance BRDG1 activity. BRDG1 is implicated in integrin-mediated signaling pathways, and FAK inhibitors may increase the reliance on BRDG1 for signal transduction. | ||||||
W-7 | 61714-27-0 | sc-201501 sc-201501A sc-201501B | 50 mg 100 mg 1 g | $166.00 $306.00 $1675.00 | 18 | |
W-7 inhibits calmodulin, which can upregulate calcium signaling pathways. Given that BRDG1 is activated by calcium-dependent mechanisms, W-7 may indirectly increase the functional activity of BRDG1 by elevating intracellular calcium levels. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
S1P engages S1P receptors, initiating signaling cascades that can enhance the activity of proteins like BRDG1. The binding of S1P to its receptors can lead to RhoA activation, a pathway where BRDG1 functions as a mediator, thus potentially enhancing its activity. | ||||||
LFM-A13 | 62004-35-7 | sc-203623 sc-203623A | 10 mg 50 mg | $119.00 $670.00 | ||
LFM-A13 inhibits Bruton's tyrosine kinase (Btk), which can lead to the preferential activation of alternative pathways that involve BRDG1. Inhibition of Btk may enhance BRDG1-mediated signal transduction as part of a compensatory cellular response. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
PGE2 acts on its GPCR EP receptors, which may lead to enhanced BRDG1 activity through EP receptor-mediated signaling pathways known to engage BRDG1. This interaction can lead to increased cytoskeletal reorganization and cellular responses where BRDG1 is active. | ||||||
YM 254890 | 568580-02-9 | sc-507356 | 1 mg | $510.00 | ||
YM-254890 specifically inhibits the Gq protein, which could lead to the enhancement of alternative signaling pathways, including those involving BRDG1. Inhibition of Gq protein may result in upregulated BRDG1 activity to maintain signaling output. | ||||||
Hydrogen Peroxide | 7722-84-1 | sc-203336 sc-203336A sc-203336B | 100 ml 500 ml 3.8 L | $31.00 $61.00 $95.00 | 28 | |
H2O2 is involved in reactive oxygen species (ROS)-mediated signaling pathways. ROS can activate tyrosine kinases that phosphorylate BRDG1, enhancing its functional activity as part of the cellular response to oxidative stress | ||||||